Banking

One-fourth of the total population is vaccinated in the US

According to a Centers for Disease Control and Prevention report, the vast majority of citizens have been vaccinated at least once, and the United States has the world’s highest vaccination rates. One-fourth of the total population has been immunized with the vaccine, with 15% fully vaccinated.

Credit Suisse in firing line after Archegos losses

ZURICH/NEW YORK (Reuters) – Pressure was mounting on Credit Suisse on Tuesday over losses linked to the downfall of Archegos Capital, with analysts warning its dividend and share buyback plans may need to go on hold and investors advised to vote against management pay.

Roche buys GenMark for $1.8 million to challenge test rivals

ZURICH (Reuters) – Roche is filling a testing portfolio gap by buying U.S.-based GenMark Diagnostics in a $1.8 billion deal that the Swiss pharmaceuticals manufacturer said taps one of the fastest-growing diagnostics areas.

Banks boost European stocks as recovery hopes grow

(Reuters) – Shares of banks and automakers lifted European shares on Monday as investors continued to move into economy-linked sectors on hopes of a solid economic rebound from the coronavirus downturn.

One-fourth of the total population is vaccinated in the US

According to a Centers for Disease Control and Prevention report, the vast majority of citizens have been vaccinated at least once, and the United States has the world’s highest vaccination rates. One-fourth of the total population has been immunized with the vaccine, with 15% fully vaccinated.

Credit Suisse in firing line after Archegos losses

ZURICH/NEW YORK (Reuters) – Pressure was mounting on Credit Suisse on Tuesday over losses linked to the downfall of Archegos Capital, with analysts warning its dividend and share buyback plans may need to go on hold and investors advised to vote against management pay.

Roche buys GenMark for $1.8 million to challenge test rivals

ZURICH (Reuters) – Roche is filling a testing portfolio gap by buying U.S.-based GenMark Diagnostics in a $1.8 billion deal that the Swiss pharmaceuticals manufacturer said taps one of the fastest-growing diagnostics areas.

Banks boost European stocks as recovery hopes grow

(Reuters) – Shares of banks and automakers lifted European shares on Monday as investors continued to move into economy-linked sectors on hopes of a solid economic rebound from the coronavirus downturn.

Categories